Caggiano Anthony
Chief Medical Officer
Caggiano Anthony has filed 4 SEC Form 4 filings (7 transaction rows) across 1 company, with disclosures dating back to 2025. 4 of those filings fall inside the rolling window. Most recent filing: Apr 20, 2026.
On the most recent filing, Caggiano Anthony is listed as Chief Medical Officer at COGNITION THERAPEUTICS INC. Inside the rolling window, Caggiano Anthony reported 1 open-market purchase totaling $11K in CGTX and no open-market sales.
Companies traded
Other insiders at CGTX
Insider Buying
$11K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Caggiano Anthony made?
Caggiano Anthony has filed 4 SEC Form 4 filings (7 transaction rows) across 1 company since 2025.
Which companies does Caggiano Anthony trade?
Caggiano Anthony has filed SEC Form 4 disclosures for 1 company, including CGTX.
When was Caggiano Anthony's most recent SEC Form 4 filing?
Caggiano Anthony's most recent SEC Form 4 filing on Tracefour is dated Apr 20, 2026.
What is Caggiano Anthony's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Caggiano Anthony is listed as Chief Medical Officer.
What is Caggiano Anthony's total buy and sell value in the current window?
Inside the rolling retention window, Caggiano Anthony bought $11K and sold $0 based on SEC Form 4 filings.
What was Caggiano Anthony's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 10,000 CGTX shares on 2026-04-16, worth $11K, per SEC Form 4 filings.